|
Orthologous residues
|
|
H2B (human): S37‑p, H2B (mouse): S37‑p, H2B (rat): S37‑p, H2B (cow): S36‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
MEF (fibroblast)
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
AMPKA1 (mouse)
|
pharmacological activator of upstream enzyme, genetic knockout/knockin of upstream enzyme, pharmacological inhibitor of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
2-deoxyglucose
|
|
|
|
increase
|
|
|
AICAR
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
transcription, altered
|
|
Comments:
S37 phosphorylation essential for cell survival in response to metabolic stress.
|